ThermaCare fits Wyeth Consumer Healthcare's strategy to accelerate growth through innovation, organic geographic growth and strategic acquisitions in the division's base business, which includes some of the world's best-selling pain management, respiratory, nutritional, gastrointestinal and topical products. ThermaCare will join the company's pain franchise that includes Advil—one of the world's leading oral pain relievers—and will enhance Wyeth's global position in pain management.
"ThermaCare is a great brand and a strategic fit for our pain management franchise," says Cavan Redmond, president, Wyeth Consumer Healthcare. "We are excited about the brand's growth potential. Millions of consumers have relied on ThermaCare for consistent, uniform heat to help them be as active as they want to be."
ThermaCare is currently sold in the U.S., Canada, Germany, the UK, Ireland, Switzerland and Austria. They are made in an Albany, GA facility that will be maintain by Wyeth after the transaction.